RecruitingNCT06316830
About this title
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose
Read the official source — NCT06316830Official study titleRandomized Clinical Trial of a 16 mg vs. 24 mg Maintenance Daily Dose of Buprenorphine to Increase Retention in Treatment Among People With Opioid Use Disorder
In ProvidenceAddictionMedication studyAges 18+
- Countries
- United States
- Sponsor
- Rhode Island Hospital
RecruitingACTRN12615000296538
Official study titleIn children and adolescents, is assessment of ADHD using the novel "EfA system" as effective and sensitive as other known methods in reaching a high quality and accurate diagnosis?
In New ZealandADHDInterventional studyAges 6–18
- Countries
- New Zealand
- Sponsor
- Dr. Yariv Doron
RecruitingNCT07503067
About this title
Identifying Substance Use Consequences
Read the official source — NCT07503067Official study titleDevelopment and Validation of a Measure of Substance-Related Consequences: A Novel Clinical Outcome Assessment for Substance Use Disorder Trials
In BelmontAddictionObservational studyAges 18+
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)
RecruitingACTRN12626000685314
In AustraliaDepression, Suicidality, ...Observational studyAges 15–25
- Countries
- Australia
- Sponsor
- Orygen
RecruitingNCT06384196
About this title
Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression
Read the official source — NCT06384196Official study titleIdentity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression: Engagement, Efficacy, and Predictors of Outcome
Multiple locations, including BadalonaDepression, AnxietyBehavioural studyAges 16–29
- Countries
- Spain
- Sponsor
- University of Barcelona
RecruitingNCT05655390
About this title
iFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)
Read the official source — NCT05655390Official study titleThe SURVIVE 2 Project: An Extended Cohort Study to Investigate Suicidal Behavior in Spain and the Efficacy of Secondary Prevention Strategies: iFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)
Multiple locations, including BarcelonaSuicidalityBehavioural studyAges 18+
- Countries
- Spain
- Sponsor
- Iria Grande
RecruitingNCT06648642
About this title
Image-guided, Robot Navigated Transcranial Magnetic Stimulation (IR-TMS) for Alcohol Use Disorder (AUD)
Read the official source — NCT06648642Official study titleAn Open-label Clinical Trial of IR-TMS for AUD and Development of a Neurobiological Biomarker for Craving and Relapse Validated Using a Direct Biochemical Biomarker (Phosphatidylethanol) of Alcohol Use
In San AntonioAddictionDevice studyAges 18–65
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center at San Antonio
RecruitingNCT06346301
About this title
Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.
Read the official source — NCT06346301Official study titleImagery Rescripting for Obsessive Compulsive Disorder and Body Dysmorphic Disorder: a Multiple-Baseline Single-Case Experimental Design.
In Amsterdam-ZuidoostBody dysmorphic disorder, OCD, ...Behavioural studyAges 18+
- Countries
- Netherlands
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
RecruitingNCT07362511
About this title
Imagery Rescripting in Primary Care
Read the official source — NCT07362511Official study titleImagery Rescripting Within Primary Care to Manage Depression: A Single-Case Experimental Design
In AmsterdamDepressionBehavioural studyAges 18–70
- Countries
- Netherlands
- Sponsor
- University of Amsterdam
RecruitingACTRN12619001713189
In AustraliaDepressionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- University of Technology Sydney
RecruitingNCT01730781
About this title
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Read the official source — NCT01730781Official study titleCharacterization of CB1 Receptors Using [11-C]OMAR
In New HavenSchizophrenia, PTSDObservational studyAges 18–55
- Countries
- United States
- Sponsor
- Yale University
RecruitingNCT07612631
About this title
Imaging CRF X NOP Interactions in Alcohol Use Disorder
Read the official source — NCT07612631Official study titleDoes a Hyperactive Nociceptin Opioid Peptide Receptor System Promote Relapse in Heavy Drinking AUD Subjects: a [C-11]NOP-1A and Hydrocortisone PET Study
In PittsburghAddictionMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Rajesh Narendran